Research led by a physicist at the University of California, Riverside, shows how viruses form protective shells (capsids) ...
The work, described in a preprint paper, has the potential to create new treatments and accelerate research into artificially ...
Pharmaceutical Technology on MSN
VectorY enters agreement with Shape Therapeutics for AAV capsid
VectorY Therapeutics has signed an agreement securing an exclusive option to assess Shape Therapeutics’ SHP-DB1 AAV capsid.
A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...
American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a ...
Five key tech terms reshaping online shopping from mobile payments and instant delivery to social media commerce and ...
The relationships we form as adults often echo those we had with our parents. According to attachment theory—one of the most ...
Shape Therapeutics Inc. could bring in as much as $1.2 billion in a new option and license deal with Vectory Therapeutics BV. It’s another collaboration for both companies that are known for working ...
At first, Ethel Branch thought her two-year-old son, Patro, had a cold or maybe the flu. Frantic, Branch rushed Patro to the ...
Sportschosun on MSN
Legend, L.A. Senior, Son Heung-min is already in love with the Happy Virus...Look at the ceremony! I...
Son National'Son National'Son Heung-min (LAFC)'s 'Happy Virus' is drawing attention locally. Italian soccer legend Giorginio ...
Scientists from Duke-NUS Medical School, in collaboration with researchers in Nepal, have found that waning immunity to Japanese encephalitis virus (JEV) may increase the risk of more severe dengue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback